AIP
GILD icon

Avail Investment Partners’s Gilead Sciences GILD Stock Holding History

Avail Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Sell
2,456
-29
-1% -$3.82K 0.24% 121
2026
Q1 		$346K Buy
+2,485
New +$348K 0.37% 78

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avail Investment Partners's GILD Position: Q2 2026 in Review

Avail Investment Partners reduced its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, selling an estimated $3.82K and leaving 2,456 shares worth $310K. The position accounts for 0.24% of the portfolio, ranked #121.

Avail Investment Partners first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $346K in Q1 2026. 2,262 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Avail Investment Partners held 2,456 shares of Gilead Sciences worth $310K as of Q2 2026.
  • Avail Investment Partners sold 29 Gilead Sciences shares in Q2 2026, an estimated $3.82K.
  • Gilead Sciences made up 0.24% of Avail Investment Partners's portfolio in Q2 2026, its #121 holding.
  • Avail Investment Partners first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Avail Investment Partners's Gilead Sciences position peaked at $346K in Q1 2026.
  • 2,262 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Avail Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.